Thrombectomy Clinical Trials

Clinical trials related to Thrombectomy Procedure

TACTIC Coronary Thrombus Aspiration With Cath Rx In Anterior Myocardial Infarction: A Randomized Control Trial.

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The aim of this study is to evaluate the impact of sustained thrombectomy with INDIGO ASPIRATION SYSTEM using CAT RX versus no thrombectomy during primary percutaneous coronary intervention (PPCI) on microvascular obstruction and infarct size, as measured by cardiovascular magnetic resonance (CMR) between 3 and 5 days post PPCI, in patients with anterior STEMI

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:

• Age \>18 and \<75 years old

• Acute anterior STEMI with ≥2 mm in two (2) or more contiguous anterior leads or ≥4 mm total ST-segment deviation sum in the anterior leads V1-V4 AND anterior wall motion abnormality noted on a diagnostic quality left ventriculogram or echocardiogram

• Culprit lesion proximal or mid LAD at coronary angiography

• TIMI thrombus grading \> 3 or TIMI flow 0 after guidewire crossing the lesion.

• Patient presents to the hospital between 1 - 6 hours of ischemic pain onset

• Patient indicated for primary percutaneous coronary intervention (PPCI)

Locations
Other Locations
Italy
IRCCS Ospedale San Raffaele
RECRUITING
Milan
Contact Information
Primary
Phani Krishna KONDAMUDI
pkondamudi@cerc-europe.org
+33 (0)1 60 11 17 91
Time Frame
Start Date: 2026-02-18
Estimated Completion Date: 2027-05-31
Participants
Target number of participants: 140
Treatments
No_intervention: Subjects randomized to the control arm will be treated with standard PPCI
Subjects randomized to the control arm will be treated with standard PPCI
Experimental: - Treatment arm: Subjects randomized to the treatment arm will be treated with the CAT RX
Treatment arm: Subjects randomized to the treatment arm will be treated with the CAT RX
Sponsors
Leads: Ceric Sàrl
Collaborators: European Cardiovascular Research Center

This content was sourced from clinicaltrials.gov

Similar Clinical Trials